Literature DB >> 20668456

A critical role of sympathetic nerve regulation for the treatment of impaired daily rhythm in hypertensive Dahl rats.

Jun-ichi Suzuki1, Masahito Ogawa, Noriko Tamura, Yasuhiro Maejima, Kiyoshi Takayama, Koji Maemura, Kazuki Honda, Yasunobu Hirata, Ryozo Nagai, Mitsuaki Isobe.   

Abstract

There is a deep relationship between impaired circadian rhythm and hypertension. However, the detailed mechanisms between the daily sleep-wake rhythm and cardiovascular disorders have not yet been elucidated. To clarify the mechanism, we examined salt-sensitive Dahl rats that were fed normal chow (n=10), high-salt chow (n=10) and high-salt chow with bisoprolol (n=10). Simultaneous electroencephalogram, electromyogram and locomotor activity were examined to analyze the sleep-wake state. We also examined heart rate, blood pressure and echocardiographic findings to verify the presence of hypertension. Hypertension with impaired ventricular contraction was observed in the rats with high-salt-chow consumption whereas normal-chow rats did not show these disorders. Although rats with the normal diet showed a standard daily rhythm with normal rapid eye movement (REM) sleep duration and locomotor activity, the high-salt-diet group exhibited an impaired daily rhythm with suppressed REM sleep and significant abnormal locomotor activity. Bisoprolol significantly improved the daily sleep-wake rhythm and locomotor activity. We showed that an impaired daily rhythm was closely related to the development of hypertension. Regulation of sympathetic nerve alterations may have a key role in the treatment of hypertension and circadian rhythm disorder.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20668456     DOI: 10.1038/hr.2010.125

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  7 in total

1.  A role for the circadian clock protein Per1 in the regulation of aldosterone levels and renal Na+ retention.

Authors:  Jacob Richards; Kit-Yan Cheng; Sean All; George Skopis; Lauren Jeffers; I Jeanette Lynch; Charles S Wingo; Michelle L Gumz
Journal:  Am J Physiol Renal Physiol       Date:  2013-10-23

Review 2.  Mechanism of the circadian clock in physiology.

Authors:  Jacob Richards; Michelle L Gumz
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-04-10       Impact factor: 3.619

3.  A role for the circadian clock protein Per1 in the regulation of the NaCl co-transporter (NCC) and the with-no-lysine kinase (WNK) cascade in mouse distal convoluted tubule cells.

Authors:  Jacob Richards; Benjamin Ko; Sean All; Kit-Yan Cheng; Robert S Hoover; Michelle L Gumz
Journal:  J Biol Chem       Date:  2014-03-07       Impact factor: 5.157

4.  Transcriptional regulation of NHE3 and SGLT1 by the circadian clock protein Per1 in proximal tubule cells.

Authors:  Kristen Solocinski; Jacob Richards; Sean All; Kit-Yan Cheng; Syed J Khundmiri; Michelle L Gumz
Journal:  Am J Physiol Renal Physiol       Date:  2015-09-16

5.  Diurnal Timing Dependent Alterations in Gut Microbial Composition Are Synchronously Linked to Salt-Sensitive Hypertension and Renal Damage.

Authors:  Saroj Chakraborty; Juthika Mandal; Xi Cheng; Sarah Galla; Anay Hindupur; Piu Saha; Beng San Yeoh; Blair Mell; Ji-Youn Yeo; Matam Vijay-Kumar; Tao Yang; Bina Joe
Journal:  Hypertension       Date:  2020-05-26       Impact factor: 10.190

6.  Long-term renal denervation normalizes disrupted blood pressure circadian rhythm and ameliorates cardiovascular injury in a rat model of metabolic syndrome.

Authors:  Tetsuji Katayama; Daisuke Sueta; Keiichiro Kataoka; Yu Hasegawa; Nobutaka Koibuchi; Kensuke Toyama; Ken Uekawa; Ma Mingjie; Takashi Nakagawa; Masanobu Maeda; Hisao Ogawa; Shokei Kim-Mitsuyama
Journal:  J Am Heart Assoc       Date:  2013-08-23       Impact factor: 5.501

7.  Brain Angiotensin II Type 1 Receptor Blockade Improves Dairy Blood Pressure Variability via Sympathoinhibition in Hypertensive Rats.

Authors:  Takuya Kishi; Yoshitaka Hirooka; Kenji Sunagawa
Journal:  Int J Hypertens       Date:  2015-03-30       Impact factor: 2.420

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.